Stage II Breast Cancer Terminated Phase 1 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01208441RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerTreatment